HIVE vs WULF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jul 18, 2026

HIVE

47.8
AI Score
VS
WULF Wins

WULF

50.5
AI Score

Investment Advisor Scores

HIVE

48score
Recommendation
HOLD

WULF

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HIVE WULF Winner
Forward P/E 62.8931 29.7619 WULF
PEG Ratio 0 0 Tie
Revenue Growth 130.5% -1.1% HIVE
Earnings Growth -99.9% 0.0% WULF
Tradestie Score 47.8/100 50.5/100 WULF
Profit Margin -49.9% 0.0% WULF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HIVE 1M: -18.2% · 3M: +17.4% WULF 1M: -25.1% · 3M: -18.7%

Current Technical Phase

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.0 · Price: $2.83

WULF

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.5%), weak momentum, RSI 41

RSI (14): 40.8 · Price: $17.66

Fundamentals Snapshot

Metric HIVE WULF
Market Cap
Forward P/E -5.5 90.6
Trailing P/E
Revenue (TTM)
Revenue Growth 1.3% 0.0%
Gross Margin 0.4% 0.6%
Operating Margin -0.8% -3.7%
EPS -0.78 -2.96
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, WULF is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.